DELETION OF SEQUENCES UPSTREAM OF THE PROTEINASE IMPROVES THE PROTEOLYTIC PROCESSING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:64
|
作者
PARTIN, K
ZYBARTH, G
EHRLICH, L
DECROMBRUGGHE, M
WIMMER, E
CARTER, C
机构
[1] SUNY STONY BROOK, DEPT MICROBIOL, STONY BROOK, NY 11794 USA
[2] DUKE UNIV, HOWARD HUGHES MED INST, DURHAM, NC 27706 USA
关键词
ASPARTIC PROTEINASES; ZYMOGEN ACTIVATION; VIRAL MATURATION;
D O I
10.1073/pnas.88.11.4776
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human immunodeficiency virus type 1 expresses structural proteins and replicative enzymes within gag and gag-pol precursor polyproteins. Specific proteolytic processing of the precursors by the viral proteinase is essential for maturation of infectious viral particles. We have studied the activity of proteinase in its immature form, as part of a gag-pol fusion protein, in an in vitro expression system. We found that deletion of p6*, the region in pol upstream of proteinase, resulted in improved processing of the precursor. A modified proteinase is released, but it functions less efficiently than wild type. Improved autoprocessing correlates with increased accessibility of the active site region in the polyprotein carrying the p6* deletion. Our results suggest that p6* is involved in the regulation of proteinase activation, perhaps as a region limiting the interaction of the active site and substrate binding domain with the remainder of the polyprotein. Release of p6* inhibition may be an activation step necessary for infectious particle maturation.
引用
收藏
页码:4776 / 4780
页数:5
相关论文
共 50 条
  • [41] MALIGNANCIES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    ARICO, M
    CASELLI, D
    DARGENIO, P
    DELMISTRO, AR
    DEMARTINO, M
    LIVADIOTTI, S
    SANTORO, N
    TERRAGNA, A
    CANCER, 1991, 68 (11) : 2473 - 2477
  • [42] HYDROXYCHLOROQUINE TREATMENT OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SPERBER, K
    LOUIE, M
    KRAUS, T
    PRONER, J
    SAPIRA, E
    LIN, S
    STECHER, V
    MAYER, L
    CLINICAL THERAPEUTICS, 1995, 17 (04) : 622 - 636
  • [43] THE TAT GENE AND PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CAPUTO, A
    GROSSI, MP
    ROSSI, C
    CAMPIONI, D
    BALBONI, PG
    CORALLINI, A
    BARBANTIBRODANO, G
    MICROBIOLOGICA, 1995, 18 (01): : 87 - 110
  • [44] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF NEURAL XENOGRAFTS
    CVETKOVICH, TA
    LAZAR, E
    BLUMBERG, BM
    SAITO, Y
    ESKIN, TA
    REICHMAN, R
    BARAM, DA
    DELCERRO, C
    GENDELMAN, HE
    DELCERRO, M
    EPSTEIN, LG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 5162 - 5166
  • [45] ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY OXIDATIVE STRESS
    LEGRANDPOELS, S
    VAIRA, D
    PINCEMAIL, J
    VANDEVORST, A
    PIETTE, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (12) : 1389 - 1397
  • [46] RNA PACKAGING SIGNAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HAYASHI, T
    SHIODA, T
    IWAKURA, Y
    SHIBUTA, H
    VIROLOGY, 1992, 188 (02) : 590 - 599
  • [47] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE MUTANTS
    ANSARILARI, MA
    DONEHOWER, LA
    GIBBS, RA
    VIROLOGY, 1995, 211 (01) : 332 - 335
  • [48] THE EFFECT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ON THE INFECTIOUSNESS OF TUBERCULOSIS
    NUNN, P
    MUNGAI, M
    NYAMWAYA, J
    GICHEHA, C
    BRINDLE, RJ
    DUNN, DT
    GITHUI, W
    WERE, JO
    MCADAM, KPWJ
    TUBERCLE AND LUNG DISEASE, 1994, 75 (01): : 25 - 32
  • [49] OLTIPRAZ, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    PROCHASKA, HJ
    YEH, Y
    BARON, P
    POLSKY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3953 - 3957
  • [50] THE MOLECULAR EPIDEMIOLOGY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN EDINBURGH
    HOLMES, EC
    ZHANG, LQ
    ROBERTSON, P
    CLELAND, A
    HARVEY, E
    SIMMONDS, P
    BROWN, AJL
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01): : 45 - 53